Drug intelligence / Profile preview

dexamethasone + n-acetylcysteine

Development stage
Unknown
Lead developer
Merck
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Intratympanic, Intravenous, Ophthalmic, Oral
01

Overview

Dexamethasone + n-acetylcysteine is a combination therapy consisting of dexamethasone, a synthetic glucocorticoid corticosteroid with potent anti-inflammatory and immunosuppressive properties, and n-acetylcysteine (NAC), a glutathione precursor with antioxidant activity. This combination has been investigated for synergistic effects in various clinical settings where both inflammation and oxidative stress are implicated. Notably, it has been studied for the prevention of post-embolization syndrome (PES) and liver decompensation following transarterial chemoembolization (TACE) in hepatocellular carcinoma patients[1][3][4][7][8]. It has also been explored as an otoprotective strategy to prevent hair cell damage from oxidative stress or trauma in the inner ear[2][6], as well as for corneal wound healing[5]. The rationale behind this combination is that dexamethasone suppresses inflammatory responses while NAC mitigates oxidative damage by replenishing intracellular glutathione.

Other names
dexamethasone and n-acetylcysteineDEXA + NAC
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on dexamethasone + n-acetylcysteine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dexamethasone + n-acetylcysteine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call